190414-Antech_AdvertorialeBlast
Preview Text
Leveraging Artificial Intelligence in Diagnostic Medicine
{{custommediabasic::headline_subhead_alternate_style}}
{{custommediabasic::headline_all_caps}}
{{custommediabasic::headline_less_padding_bottom}}
#006080
{{custommediabasic::brand_secondary_color}}
{{custommediabasic::custom_background}}
40px 0 30px 0
{{custommediabasic::logo_url}}
/uploads/https://cdn.brief.vet/Clients/Aratana/190197-AratanaeBlast/aratana.png
{{custommediabasic::logo_alt_text}}
200
{{custommediabasic::logo_at_bottom}}
{{custommediabasic::header_image_url}}
/uploads/https://cdn.brief.vet/Clients/Antech/190414-Antech_AdvertorialeBlast/headerv1.jpg
{{custommediabasic::header_image_alt_text}}
Leveraging Artificial Intelligence in Diagnostic{nbs}Medicine
{{custommediabasic::headline_smaller}}
Moving from Disease Detection to Disease{nbs}Prediction
{{custommediabasic::subhead_url}}
{{custommediabasic::headline_subhead_above_header_image}}
true
By the time traditional biomarkers for kidney disease are elevated, anywhere from 25%-40% of kidney function is already lost. However, artificial intelligence is changing the future of veterinary medicine. Imagine if you could predict which of your feline patients will develop chronic kidney disease in the future. RenalTech{trade}, a first-of-its-kind diagnostic test, relies on artificial intelligence to allow veterinarians to develop more personalized patient care plans and implement preventive care before organ damage is{nbs}underway.
{pb10}Learn how the RenalTech{trade} algorithm:{/pb10}
- Predicts whether a cat will develop CKD within 2{nbs}years
- Has greater than 95% accuracy
- Allows for earlier intervention
- Supports the value of preventive{nbs}care
#888888
{{custommediabasic::cta_big}}
{{custommediabasic::cta_center}}
{{custommediabasic::cta_callout}}
{{custommediabasic::cta_callout_secondary}}
http://google.com
Discover how you can harness the power of artificial intelligence in your{nbs}practice.
Learn More
{{custommediabasic::footnote_center}}
IMPORTANT SAFETY INFORMATION: ENTYCE{reg} (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more{nbs}detail.
{{custommediabasic::footnote_larger}}
{{custommediabasic::pre_footer_center}}
{{custommediabasic::pre_footer_larger}}
{{custommediabasic::pre_footer_copy}}
Leveraging Artificial Intelligence in Diagnostic Medicine
|
|
Leveraging Artificial Intelligence in Diagnostic{nbs}Medicine
|
Moving from Disease Detection to Disease{nbs}Prediction
|
By the time traditional biomarkers for kidney disease are elevated, anywhere from 25%-40% of kidney function is already lost. However, artificial intelligence is changing the future of veterinary medicine. Imagine if you could predict which of your feline patients will develop chronic kidney disease in the future. RenalTech{trade}, a first-of-its-kind diagnostic test, relies on artificial intelligence to allow veterinarians to develop more personalized patient care plans and implement preventive care before organ damage is{nbs}underway. {pb10}Learn how the RenalTech{trade} algorithm:{/pb10} - Predicts whether a cat will develop CKD within 2{nbs}years
- Has greater than 95% accuracy
- Allows for earlier intervention
- Supports the value of preventive{nbs}care
|
Discover how you can harness the power of artificial intelligence in your{nbs}practice.
|
Discover how you can harness the power of artificial intelligence in your{nbs}practice.
|
|
IMPORTANT SAFETY INFORMATION: ENTYCE{reg} (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more{nbs}detail.
|
|
|
</head>
<body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
Leveraging Artificial Intelligence in Diagnostic Medicine
|
|
Leveraging Artificial Intelligence in Diagnostic{nbs}Medicine
|
Moving from Disease Detection to Disease{nbs}Prediction
|
By the time traditional biomarkers for kidney disease are elevated, anywhere from 25%-40% of kidney function is already lost. However, artificial intelligence is changing the future of veterinary medicine. Imagine if you could predict which of your feline patients will develop chronic kidney disease in the future. RenalTech{trade}, a first-of-its-kind diagnostic test, relies on artificial intelligence to allow veterinarians to develop more personalized patient care plans and implement preventive care before organ damage is{nbs}underway. {pb10}Learn how the RenalTech{trade} algorithm:{/pb10} - Predicts whether a cat will develop CKD within 2{nbs}years
- Has greater than 95% accuracy
- Allows for earlier intervention
- Supports the value of preventive{nbs}care
|
Discover how you can harness the power of artificial intelligence in your{nbs}practice.
|
Discover how you can harness the power of artificial intelligence in your{nbs}practice.
|
|
IMPORTANT SAFETY INFORMATION: ENTYCE{reg} (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more{nbs}detail.
|
|
|